^
Association details:
Biomarker:No biomarker
Cancer:Neuroblastoma
Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
Published date:
08/28/2020
Excerpt:
Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated...for the treatment of...metastatic neuroblastoma…